WO2012160549A2 - Bioresonance therapy - Google Patents
Bioresonance therapy Download PDFInfo
- Publication number
- WO2012160549A2 WO2012160549A2 PCT/IL2011/000412 IL2011000412W WO2012160549A2 WO 2012160549 A2 WO2012160549 A2 WO 2012160549A2 IL 2011000412 W IL2011000412 W IL 2011000412W WO 2012160549 A2 WO2012160549 A2 WO 2012160549A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- manufacture
- article
- formulation
- carrier
- radiation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Provided are homeopathic combinations, carriers imprinted with the bioresonance of said combinations and articles of manufacture comprising the same.
Description
BIORESONANCE THERAPY
Field of the Invention
The invention relates to the prevention, protection-from, and treatment of various diseases and conditions, including radiation, cancer, metabolic disorders, neurodegenerative disorders, cellular metabolic disorders, etc.
Background of the Invention
Modern clinical medicine has a sufficiently broad therapeutic potential. However, the number of cardiovascular, oncological, infectious and other diseases, continue to grow. Similarly, there is an increase in the frequent transformation of acute illnesses into chronic forms, in the percentage of allergic reactions to pharmacological agents, and in fertility problems. Accordingly, there is a constant need to seek new therapeutic approaches to minimize the dependency from modern medicine.
Moreover, the number of ionizing (e.g. radioactive and nuclear radiation) and non-ionizing radiation sources (e.g. cellular phones and nuclear energy sources) constantly increases, exposing more and more people to harmful radiation. This encourages the need to develop new means for protection therefrom.
One such therapeutic method is Bioresonance Therapy (BRT), which is a known homeopathic technique. BRT is actually considered as an electronic homeopathy in which the electromagnetic field of the therapeutic material is passed on to the fluid or other material.
Many common homeopathic remedies have been developed aiming at improving a person's health and life quality, and also as stress- and pain- relievers. Homeopathic remedies consist of minute doses of natural
substances (e.g. minerals, plant extracts or animals), that when given to healthy people in a large dose would cause the symptoms the patient is experiencing. Homeopathic remedies are shaken vigorously with each dilution to increase their vibratory field, and are thought to work by stimulating the body's own healing energy, rather like a tuning fork that sets disharmonious chords back on track. The principle of homeopathy is similar to that of pharmaceutical vaccination, but while vaccines are macromolecules that can induce unwanted side effects, homeopathic remedies are without side effects. This is because they are often diluted to such a degree that no molecule of the original substance can be detected. In fact, homeopathic remedies work by gently boosting the natural energy of the body, and are very safe, even for pregnant and sensitive patients. There is also no danger of addiction or toxicity. Bioresonance consist of various methods of application of certain frequencies or magnetic fields to the body. Bioresonance is based on the fact that all matter has a resonant frequency and every cell in the body resonates at a particular frequency. This takes the form of an electromagnetic field and groups of cells in an organ or system have multiple unique frequency patterns. Hence, the whole body has a complex frequency make-up, which can change or become distorted when affected by illness. BRT teaches that it is possible to introduce healthy frequencies to re-balance the whole body and provide an environment where the body cures itself. Similar treatments involve acupuncture and homeopathy, which rely on energy flow.
In endogenous BRT, electrical oscillations are picked up by electrodes placed on the patient's skin, which are connected by a cable to the BRT apparatus. These signals are then processed, amplified and returned back to the patient (as a closed feedback loop). This technique is based on the assumption that there are two types of electrical oscillation in living organisms: "physiological" or harmonious, and "pathological" or disharmonious
oscillations. Usually, "physiological" signals have a sinusoidal wave form, whereas "pathological" signals have more complex signals. The end result is a suppression or diminution of the pathological signals whilst the physiological signals are amplified.
BRT is a known, effective and safe therapy for various diseases and conditions, such as nervous-psychic disturbances of children (e.g. delayed mental development with syndrome of social adaptation, disturbance of speech, phobias, reactive depression, nervous and facial tics), psycho vegetative disturbances of elder people, addictions and withdrawal syndromes, including reduction of the number of used analgesics, sedatives, and tranquilizers for drug addicts. BRT is also used to improve general health, restore sleep, reduce pain symptoms and stabilize emotional sphere. In addition, BRT has been shown to significantly change psychosomatic status, reduce psychological tension, discomfort, irritability, anxiety, and aggressiveness.
BRT also includes a method of imprinting frequencies of one therapeutic composition onto another material to be administered to the patient. This method provides the benefits of the original pharmaceutical, while avoiding its downsides. As an example, it is possible to determine a medicament's frequency and then transfer said healing frequency to, e.g., water. Subsequently, drinking the treated water would provide all the benefits of the medicament, without any of its side effects. Alternatively, it is possible to determine a pathogen's frequency and then establish the appropriate counter-frequency to stimulate the change of bioresonance in the cell/body. Transmitting these transformed signals would generate healing signals with curative effect, without administering any drugs to the patient. Thus, the present invention relates to imprinting frequencies of various formulas onto a single carrier, such as, for example, water or glycerin, and
subsequently employing said carrier on the patient's body, e.g. as an ointment or cream, or embedded in a article of manufacture such as a bracelet, necklace or watch to be worn by the patient. Alternatively, the carrier itself might be used in the preparation of the article of manufacture itself (such as silicone).
Another homeopathic approach is the complex homeopathy which is different from classical homeopathy: In classical homeopathy, carefully chosen single remedies are common practice, whereas complex homeopathy consists of multiple synergistic ingredients, sometimes as many as 30 ingredients.
Accordingly, the invention relates to a complex homeopathy, which consists of at least 6 ingredients, wherein each of said ingredients might also be a complex composition. According to the invention, the bioresonance frequencies of all said ingredients are imprinted onto one single carrier.
Other objects and advantages of present invention will appear as description proceeds. Summary of the Invention
Homeopathic therapy is well known and practiced all over the world. However, the present invention is the first to provide a unique combination of known homeopathic remedies. One object of the present invention is therefore to provide a unique homeopathic combination.
According to certain embodiments, the homeopathic combination of the invention may comprise the homeopathic remedies hereinafter referred to as Formulation A; Formulation B; Formulation C; Formulation D; Formulation E; and Formulation F, wherein said Formulations are as defined in Example 1 below.
The combinations of the invention may further comprise at least one of the following homeopathic remedies: Formulation G; Formulation H; Formulation I; Formulation J; Formulation K; Formulation L; and Formulation M, wherein said Formulations are as defined in Example 1 below.
In another embodiment of the invention there is provided a carrier substance, which is imprinted with the bioresonance of the combination of the invention. Said carrier may be either solid or liquid, wherein said liquid may be selected from the group consisting of: water, oil, salt solutions, glycerin, silicon, alcohols, and any other liquid or semi-solid matter.
According to one aspect of the invention, the imprinting onto the carrier is carried out separately for each of the above Formulations. Alternatively, the various Formulations are first mixed into one single solution and the combined bioresonances are imprinted onto the carrier in a single step. Still alternatively, the various Formulations are first mixed into at least 2 solutions prior to the bioresonance transfer.
The compositions and imprinted carriers of the invention surprisingly enable treating, preventing, and/or ameliorating numerous diseases and conditions, such as cancer, infections (e.g. bacterial, viral, parasitical and fungal), metabolic disorders, neurodegenerative disorders, infertility, autoimmune diseases, immune deficiencies, heart diseases, and skin diseases.
The compositions and imprinted carriers of the invention surprisingly also enable treating, preventing, and/or ameliorating migraines, stress-related conditions, menstrual pains, and/or allergic reactions. They are further suitable for ameliorating any side effects resulting due to chemotherapy, radiotherapy and/or any other harmful or chronic therapy.
The compositions and imprinted carriers of the invention are suitable for treating Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) patients.
The compositions and imprinted carriers of the invention are suitable for therapy and may be either administered orally to the patient or be implanted into a wearable article of manufacture. The term "article of manufacture" encompasses a broad spectrum of products, including, but not limited to, an ornament such as a bracelet, a necklace, or a ring. Alternatively, the article of manufacture may be composed essentially from the imprinted carrier.
The article of manufacture of the invention surprisingly proven to be effective in reducing the symptoms of various diseases and conditions, including cancer, infections, metabolic disorders, neurodegenerative disorders, infertility, autoimmune diseases, heart diseases, and skin diseases.
The article of manufacture of the invention surprisingly proven to be effective in protecting the wearer from the harmful effects of radiation (such as radioactive radiation, ionizing radiation, non-ionizing radiation, such as cellular irradiation, and electromagnetic radiation). Examples of potential patients are people how work in airports or ships, radar operators, or any one who works in an electromagnetic environments, e.g. army soldiers, air crew and security personal. Other examples are subjects exposed to Xray radiation, e.g. passengers in airports, patients in hospitals, etc. A method of preparing the article of manufacture of the invention is also disclosed herein. In certain embodiments, the method for preparing the article of manufacture of the invention comprises: preparing the article of manufacture, in any common way; and inserting therein the carrier or the
combination of the invention. Alternatively, the article of manufacture of the invention may be prepared by mixing the carrier with a stabilizing material, e.g. a plasticizer, and subsequently preparing the article of manufacture in any known method, e.g. press mold or cast mold.
For instance, a hollow plastic tube can be filled with a carrier of the invention and then shaped into a circular bracelet, or the plastic material may imbed the carrier of the invention.
A method of treating a patient, comprising causing said patient to wear the article of manufacture of the invention, is also disclosed herein.
Brief Description of the Drawings
The above and other characteristics and advantages of the invention will be further illustrated through the following examples, and with reference to the appended drawings, wherein:
Fig. 1. is a Western-blot with anti-p53 antibodies. Figure la shows the increase in p53 level in cells exposed to cellular irradiation for 1, 2, and 3 hours. Figure lb shows that SR18 reduced the amount of p53 in both rested and irradiated cells.
Fig. 2. is a Western-blot with anti-phospho-ERK antibodies. Figure 2a shows the increase in ERK's phosphorylation in cells exposed to cellular irradiation for 5, 10, 15, 20 and 30 minutes. Figures 2b and 2c show that SR18 completely inhibited ERK phosphorylation in both rested and irradiated cells.
Fig. 3. is a Western-blot with anti-phospho-ERK antibodies. Figures 3a and
3b show that SR18 potentiated ERK phosphorylation in response to EGF stimulation, compared to untreated cells.
Detailed Description of the Invention
Bioresonance therapy (BRT) is a form of electromagnetic therapy in alternative medicine, which was invented in Germany in 1977, under the name "MORA-Therapie". Most of the devices used in BRT contain an electronic circuit measuring skin-resistance, like the E -Meter in Scientology.
In some of these devices a modern signal processing technique, usually PC- based, is able to analyze the multiple parameters of the response and interpret the results. The analyst is then able to make an assessment/summary of the physical and mental health of the patient. Known devices are, e.g. Bicom from REGUMED Regulative Medizintechnik GmbH Hans-Cornelius-StraBe 4 D-82166 Grafelfing, Germany; Vega from VEGAMED eganzheitlicher medizin; and Best from BEST- systems.
Said devices may also be used by practitioners to treat diseases by stimulating a change of bioresonance in the cells, by reversing the resonance- change caused by the disease, and transmitting this transformed signal over the same electrodes back to the patient.
Similar devices may be used to transmit the frequency spectra (bioresonance) of bio-information in a simple manner, store it and duplicate it or transfer it to another carrier, e.g. from homeopathic substances, nosodes, Bach flower remedies, patient's blood and other substrates, to a carrier such as water, alcohol or other liquid. Examples of such devices are the WAVE TRANSFER and MEDICUP from W. LUDWIG® of the Institute for Biophysics, Tauberbischofsheim; and IMEDIS-BRT from IMEDIS Center of Intelectual Medical Systems. Said devices may also potentiate the transferred frequency for better therapeutic results.
Accordingly, the present invention relates to the transfer of the bioresonance of homeopathic substances onto a carrier. Said transfer may further include the amplification of the imprinted bioresonance. The invention further relates to the transfer of the bioresonance of at least six homeopathic substances, which are mixed together to form a single mixture, onto a carrier. Alternatively, the transfer of the bioresonance of said at least six homeopathic substances may be done by transferring their bioresonance onto the carrier one by one. Many homeopathic formulas have been developed to address almost any condition such as metabolism imbalances (e.g. excess anabolic states, excess catabolic states, tissue receptivity to testosterone, tissue receptivity to insulin, and regenerating the beta cells of the pancreatic islets of Langerhans, etc.), reducing anti-oxidant levels in the body, modify the activity of protease enzymes, reduce mental stress, utilization of energy and oxygenation within the cell, modify the activity of the parasympathetic nervous system, and may more. One such remedies series is the Apex Energetics Metaboplex. Accordingly, one object of the invention is to combine several known remedy formulas into a single mixture and use thereof in therapy, wherein the result so obtained comprises substantial and unexpected synergy. In another object of the invention, the bioresonance of said formulas is transferred (imprinted) onto a carrier, wherein said carrier is used for therapy, optionally by implanting it into an article of manufacture worn by the patient, such as a bracelet or a necklace.
About 400 known genes are involved in causing cancer due to mutations therein. Only about 40 genes are responsible for suppressing or preventing cancer formation (tumor suppressor genes). Examples of such suppressor genes are p53, pRb (Retinoblastoma protein), PTEN, APC, CD95, ST5, ST7,
and ST 14. Among these, p53 is extremely important as it identifies defects in the genome and initiates programmed cell death, thus preventing the cell from becoming cancerous. It is known that under stress conditions, e.g. radiation, such as radioactive radiation or even cellular phone irradiation, cells react by elevating the amount of tumor suppressor proteins. This elevation may be in response to an increase in reactive oxygen species (ROS) in the cells. It has now been found that various homeopathic remedies are useful for reducing the effect of stress on cells. Although treatments of this type are known, the present invention is the first to provide unique combinations of remedies and distinctive ways of applying them. Accordingly, the invention relates to a wearable article of manufacture containing the unique combination of homeopathic remedies of the invention, which is useful to protect the cells and body from various stress conditions. Said combinations of homeopathic remedies may by either the actual mixture of said remedies, or a single carrier which was imprinted with the bioresonance of each of said remedies. In addition, it is possible that during said imprinting process, the transferred frequencies are amplified.
The term "stress conditions" is to be understood as referring to any mental, emotional, physical or biological condition, whether actual or imagined. The inventive homeopathic combinations of the invention may be used advantageously for treating cancer, infections (e.g. bacterial, viral, parasitical and fungal), metabolic disorders, neurodegenerative disorders, infertility, autoimmune diseases, heart diseases, and skin diseases. To this end, the homeopathic combinations are introduced into a wearable article of manufacture.
The invention further relates to a method for producing the wearable article of manufacture containing a unique combination of the invention or the carrier imprinted with the bioresonance of said combination. The wearable article of manufacture of the invention is kept next to the patient body, thus enabling protection and healing effects.
Production of the articles of manufacture of the invention can be done by any known method such as solvent-casting method, hot-melt extrusion process, or as solidified foams. The articles of manufacture can be in any shape or form (such as square, rectangular, circular, oval, etc.). The articles of manufacture of the invention may further contain plasticizers, dispersants and/or stabilizers that increase the plasticity, fluidity and/or stability of the material. The term "patient" as used herein includes human and non-human animals. The patient to be treated is preferably a mammal.
The terms "treatment", "treating" and "treat", as used herein, include their generally accepted meanings, i.e., the management and care of a patient for the purpose of preventing, prohibiting, restraining, alleviating, ameliorating, slowing, stopping, delaying, or reversing the progression or severity of a disease, disorder, or pathological condition, described herein, including the alleviation or relief of symptoms or complications, or the cure or elimination of the disease, disorder, or condition.
The following examples are set forth to further illustrate the homeopathic combinations and articles of manufacture of the invention. The below examples, however, should not be construed as limiting the present invention in any manner.
Formulations useful in the invention
The meaning of X, C, and LM, in the following examples relates to the number of dilutions. Accordingly, for example, 2X means that a unit volume was diluted ten fold, from which another unit volume was taken, which was further diluted again ten fold.
The Latin names and terms mentioned in the following examples are well familiar to experts in the field. Formulation A
Relieves stress and sadness, reduces adrenal exhaustion, and treats allergies and fatigue. Also known as B-2 Adrenal Peptm, from Apex Energetics. The composition comprises:
Material Content
Phosphoric acid 6X 9X 12X 30X
Adrenaline, Thyroidinum (dried thyroid gland of the ^
sheep)
Balsam Peruvian 6X 9X
Damiana, Licorice IX
Aralia Quinquefolia 2X
Potassium phosphate 6X 8X 10X 12X
Selenium 10X 12X 15X
Phosphate of Lime 10X 12X
Arsenite of Quinine 4X 6X 8X 12X
Lycopodium 6X 9X 12X
Carpinus, olive, cherry plum, impatiens, star of ^ g^,
bethlehem, clematis, rock rose
Arnica montana 6X 9X 12X
Cinchona officinalis 4X 6X 8X 12X
Acetic acid 8X 12X 15X 30X
Phosphorus 8X 12X 30X
Pituitary Posterior 15X
Formulation B
Stimulates the integration of metabolites into the cells. Helps to excrete excess sodium. For relief of symptoms related to minor cellular degeneration and free-radical damage. Also useful for treating fatigue, inflammation of the middle ear, vomiting in infants, hiccough, and fever.
Also known as C-3 Cell Metabolism, from Apex Energetics. The composition comprises:
Material Content
Fluoride of Lime, Cobalt, Sodium carbonate, Selenium 9X 12X
Silica 12X 15X
DNA, RNA 4C 7C 9C
Molybdenum 9X 12X
Iodide of Sulphur 6X 8X 10X
Iron 9X 12X 15X
Silicone Fluoride of Lime 8X 10X 12X
Magnesium acetate, Sodium chloride, Co-enzyme Q10 6X 9X 12X
Citric acid 8X 10X 12X
Acetic acid 6X 8X 12X
Germanium 10X 12X 14X
Zinc 10X 12X 15X
Lecithin 4X 6X 8X
Lactic acid 6X 9X
Sarcolactic acid 4X 8X
Formulation C
Useful for relief of fatigue, nervous irritability, muscle cramps, water retention, urinary discomfort, and loss of appetite. Also known as D-l Drainage Complex™, from Apex Energetics. The composition comprises:
Material Content
Glycyrrhiza Glabra, Alfalfa, Passiflora Incarnata, 1 1 Λ
Avena Sativa
Allium Sativum 2X 4X 6X 8X
Asparagus Officinalis 2X 4X 8X
Belladonna 3X 6X 15X
Berberis Vulgaris 3X 6X
Solidago Virgaurea 3X 6X
Che lido nium Majus 2X 4X 6X 10X
Hydrastis Canadensis 2X 8X 12X
Juniperus Virginiana 4X 6X
Niccolum Metallicum 10X 12X
Sarcolacticum Acidum 6X 10X 15X 30X
Taraxacum Officinale 2X 4X 6X
Formulation D
Useful for treating radiation symptoms (X-rays, geopathic stress, electromagnetic stress, etc.). Also useful against inflammation, fatigue and weakness, and anemia. Also known as N-4 Radiatio Antitox™, from Apex Energetics. The composition comprises:
Material Content
Aloe Socotrina 4X 6X 9X 12X
Bone Marrow, Hematopoietic Tissue, Placenta, Skin 4C 7C
DNA 4X 8X 12X
Echinacea Angustifolia, Echinacea Purpurea 2X 4X 6X
Ferrum Metallicum 10X 12X 15X 30X
Fucus Vesiculosus 3X 6X 9X
Lecithin 3X 6X 9X
Iodum 6X 9X 12X 30X
Kali Phosphoricum 6X 9X 12X 30X
Phosphorus 9X 12X 15X 30X
Ribes Nigrum Gemmae 3X 5X 8X
Vitamin A 4X 6X 9X
Vitamin E 4X 6X 9X
Formulation E
Suitable for treating mental or physical exhaustion, and chemical or food hypersensitivities. Also known as G-12 ATP-MET™, from Apex Energetics. The composition comprises:
Material Content
8X 9X 12X
Calcium Carbonica
4C 5C 6C 7C
2X 3X 6X 8X 12X
Spongia Tosta
1C 2C 3C 5C 6C 7C
5X 6X 8X 12X
Phosphorus 3C 5C 6C 7C
2LM
Petroleum 1LM
Lycopodium 1LM
Testosterone 3C 4C
Ammonium Muriaticum 4C 5C 6C
Adenosine Triphosphate 5X
Formulation F
Accentuates the effect of all emotional therapies and flower remedies. Helps in treating mental/emotional stress, sadness, and nervous irritability. Also known as R- 7 Pituitary, horn Apex Energetics. The composition comprises:
Material Content
2X 3X 6X 8X 12X
Veratrum Album
2C 3C 5C 6C 7C
. p, , . 6X 8X 12X
Magnesia Phosphorica 5Q QQ
3X 6X 8X 12X
Nux Vomica
3C 5C 6C 7C
3X 6X 8X 12X
Ignatia Amara
2C 3C 5C 6C 7C
Ammonium Carbonicum 4C 5C 6C
Crocus Sativus 1LM
Adenosine Triphosphate 5X
Formulation G
For relief of symptoms related to low-level toxic bioaccumulation in cleansing organs such as liver, kidneys, and lymphatics. Enhances the body's own
"detox-ability" for an effective cleansing. Also known as A-3 Ultra Antitox™, from Apex Energetics. The composition comprises:
Material Content
Berberis Vulgaris, Solidago Virgaurea, Taraxacum
Officinale, Carduus Marianus, Uva Ursi, Passiflora IX
Incarnata, Alfalfa, Avena Sativa, Chamomilla
Asparagus Officinalis 2X
Aralia Quinquefolia 2X
Lapis Albus 12X 15X
Chelidonium Majus 3X 5X 7X
Lycopodium Clavatum 3X 6X
Scrophularia Nodosa 3X
Ferrum Iodatum 8X 10X 12X
Baryta Iodata 8X 10X 12X
Apis Mellifica 3X 6X
6X 9X 12X
Bryonia 15χ
Conium Macula turn 6X 8X 12X
Natrum Carbonicum 6X
Formulation H
For homeopathic cleansing of the gastrointestinal tract and balancing the flora as well as relief of symptoms related to disturbances in this area. Also suitable for Candida and uric acid-related conditions. Also known as A- 4 Deep Antitox™, from Apex Energetics. The composition comprises:
Material Content
12X 15X 20X 30X 60X
Candida Albicans
200X
Carbo Vegetabilis 8X10X12X
Colchicum Autumnale 6X 9X 30X
12X 15X 20X 30X 200X
Lacticum Acidum
Uric Acid 8X 10X 12X 15X
Skatolum, Indolum 10X 12X 15X 30X
Aloe Socotrina IX 4X 6X 8X 10X 15X Calcarea Iodata 8X 10X 12X 30X
Arsenicum Iodatum 6X 8X 12X 15X
Baptisia Tinctoria IX 6X 9X 12X 15X
Chelidonium Majus IX 2X 12X 15X 30X
Scrophularia Nodosa IX 5X 7X 9X 12X 30X Asterias Rubens 4X 6X 8X
Sarcolacticum Acidum 30X 200X
Sulphur 12X
Lac Vaccinum 6X 12X 30X 60X 200X
Millefolium, Echinacea Angustifolia,
Echinacea Purpurea, Solidago Virgaurea, IX
Allium Sativum, Allium Cepa
Saccharum Officinale 12X 30X 60X 200X
Cina, Cinchona Officinalis 3X
Formulation I
Used for detoxification and desensitization, and can relief symptoms related to environmental stress factors, and for organ function support. Also known as A- 11 Enuiroprotect™, from Apex Energetics. The composition comprises:
Material Content
Carboneum Oxygenisatum 8X 12X 15X 30X
12X 15X 30X 60X
House Dust
100X
Tobacco 8X 10X 12X 15X
Chlorinum 8X 12X 15X 30X
Plumbum Metallicum 12X 15X 20X 30X
Phenol 6X 9X 12X 15X 30X
Chelidonium Majus 4X 6X 8X
Berberis Vulgaris 4X 6X 8X 10X
Solidago Virgaurea 4X 6X 9X
Que reus Pedonculata Gem 3X 6X 9X
Vitamin E, Crabapple 9X 12X 15X
Cadmium Metallicum 10X 12X 15X
Lycopodium Clavatum 4X 6X 8X 10X 12X
Vitamin A, Ascorbic Acid 6X 9X 12X
Niacin 6X 9X 12X
4X 6X 8X 10X
Allium Sativum
Penicillin Notatum 9X 12X 15X 30X
Hydrocarbons 12X 15X 20X 30X
Mold Mix 12X 15X 30X
Formulation J
Improves calcium and mineral metabolism for increasing stamina and endurance. Also suitable for relief of nervous irritability, weakness, fatigue, and exhaustion. Also known as B-13 Cell Salt Complex™, from Apex Energetics. The composition comprises:
Material Content
Urtica Urens, Hypericum Perforatum, Avena Sativa IX
Allium Sativum 4X 6 X 8X 10X
Calcarea Carbonica, Calcarea Sulphurica, Calcarea
10X 12X 15X 20X Phosphorica
Carbo Vegetabili, Kali Phosphoricum, Lacticum
10X 12X 15X 20X 30X Acidum, Magnesia Phos
Ferrum Iodatum, Natrum Phosphor-Icum,
10X 12X 15X 30X Phosphoricum Acidum, Calcarea Fluorica
Natrum Muriaticum 12X 15X 20X 30X 200X
Formulation K
Used for balancing the Conception Vessel and Heart Governor meridians and related emotions. Useful when the endocrine system is stressed and there is a lack of energy; also with insomnia or when traveling through time zones. Also known as E-8 Bioclock Regulator™, from Apex Energetics. The composition comprises:
Material Content
Gelsemium Sempervirens 9X 12X 15X
Calcarea Iodata 8X 12X
Lac Caninum 10X 12X 15X
Pineal, Adrenal 4C
Pituitary, Hypothalamus, Trypto-Phan, Tyrosine 7C
Ribes Nigrum Gemmae 2X 4X 8X
Eleutherococcus, Solidago, Juniperus Com. Gemmae 3X 6X 9X
Kali Phosphorica 4X 6X 9X 12X 30X
Sarcolacticum Acidum 3X 6X 9X 12X 30X
Cascara Sagrada 2X 4X 6X
Passiflora Incarnata 2X 4X 6X 12X
Betula Verrucosa Gemmae 3X 6X
Hornbeam, Olive, Star Of Bethlehem 12X 30X
Phosphoricum Acidum 4X 6X 9X 12X
Nux Vomica 6X 9X 12X 15X 30X
Sepia 6X 9X 12X 15X 30X Colchicum Autumnale, Kali Carbonica, Cocculus
6X 9X 12X
Indicus
Formulation L
For the relief of pain in and around joints related to incomplete integration of dietary metabolites. Also known as M-7 Joints, from Apex Energetics. The composition comprises:
Material Content
Vitis Vinifera Gemmae, Hydrocotyle Asiatica,
Bellis Perennis, Eupatorium Perfoliatum
Stellaria Media, Kalmia Latifolia, Formica Rufa,
Paeonia Officinalis
Jacaranda 4X
Carboneum Sulphuratum 8X
Cuprum Arsenicosum 10X
Ranunculus Bulbosus 4X
Sarcolacticum Acid 12X 15X
Strontium Carbonicum 8X 12X 15X
Hippuricum Acid 6X 8X 10X 12X
Uric Acid 6X 9X 12X 15X
Joints 4C 6C 8C IOC 12C
Formulation M
Helpful in relief of pain in and around ligaments related to incomplete integration of dietary metabolites. Also known as M-8 Ligaments, from Apex Energetics. The composition comprises:
Material Content
Colchicum Autumnale 3X 6X 9X
Solidago Virgaurea 2X
Abies Pectinata Gemmae 2X
Guaiacum 2X 4X
Lathyrus Sativus 3X
Bryonia 3X 6X
Silicea 8X 10X
Rhus Toxicodendron 6X 9X 12X
Terebinthina 4X 6X
Oleander 4X
Ammonium Phosphate 8X
Kali Iodatum 8X
GElsemium Sempervirens 12X 15X
Ligaments 4C 6C 8C IOC 12C
The above Formulations are exemplary only and should not be constructed as limiting the scope of the invention solely to their exact specified content. It is understood that any variation in any or in all of the above Formulations is applicable and encompassed by the present invention. Variations in such formulations will be apparent to experts in the field of BRT.
Examples
Example 1
Various combinations of the above remedies
Different combinations of the above Formulations are prepared, and their resonance is transferred onto a recipient/carrier, using a frequency imprinting machine. The recipient/carrier may be any desired substance. Non-limiting examples of such substances are water, salt solutions (e.g. saline solution), glycerin, oil and silicon. Any suitable frequency imprinting
machine can be used throughout the following examples, for instance Bicom from REGUMED, Vega from VEGAMED, Best from BEST- systems, WAVE TRANSFER and MEDICUP from W. LUDWIG®, and IMEDIS-BRT from IMEDIS.
The frequency transfer is performed either separately for each of the Formulations in the final combination, or for all Formulations at once, wherein said formulations may be separate or blended in one single mixture. It is to be understood that the frequency transfer of the Formulations can be done in any variation, as long as the final carrier receives all the frequencies of all the desired Formulations.
Examples of such combinations are:
1) Combi 1: Formulation A + Formulation B + Formulation C + Formulation D + Formulation E + Formulation F;
2) Combi 2: Combi 1 + Formulation G
3) Combi 3: Combi 2 + Formulation H;
4) Combi 4: Combi 3 + Formulation I;
5) Combi 5: Combi 4 + Formulation J;
6) Combi 6: Combi 5 + Formulation K;
7) Combi 7: Combi 6 + Formulation L;
8) Combi 8: Combi 7 + Formulation M;
Additional combinations include any combination that includes Combi 1 and at least one of Formulation G to Formulation M.
Example 2
SR18 inhibits cancer growth
In order to demonstrate the effect of SR18 ("Combi 8" above, in saline) on the growth of cancerous cells, its effect on 4 cancer cell lines [all received from ATCC] was determined: H293 HEK cells (Human Embryo Kidney)[ATCC No.
CRL-1573], H1299 cells (Lung Carcinoma) [ATCC No. CRL-5803] and U-2 OS (Osteosarcoma) [ATCC No. HTB-96]. The frequency of the Combi 8 was transferred to saline solution using the MORA machine from MED-TRONIK. Cell growth was determined using the methylene blue spectophotometric method, according to Marta F. Dent et ah, "The methylene blue colorimetic microassay for determining cell line response to growth factors", Cytochemistry 17/1:27-33, 1995. Shortly, the method is as follows: 1. Wash the cells with PBS, trypsinize, and add medium;
2. Centrifuge the content in room temperature for 5 minutes at 1200 RPM;
3. Remove the medium and re-suspend the pellet of cells in 25 ml medium;
4. Transfer 2 ml to each of twelve 3.8 cm tissue culture plates and leave to adhere for at least 4 hours;
5. Incubate the plates for 24 and 48 hours in duplicates as follows:
- control,
- SR18 in saline,
- SR18 in silicone wrapped around the plate (without any direct contact between SR18 and the medium or cells);
6. After 24 or 48 hours remove the medium and wash gently with PBS;
7. Fix the cells by adding 1 ml of 4% Formaldehyde for 2 hours in room temperature (in hood);
8. Wash the cells twice with 1 ml of 0.1 M Borate Buffer pH 8.5 (buffer tittered with NaOH) and stain by adding 1 ml of 1% Methylene Blue in 0.1 M Buffer pH 8.5 for 10 minutes in room temperature;
9. Rinse the plates gently in DW (Distilled Water) until the water are completely clear;
10. Leave the plates to dry;
11. Extract the color by adding 1 ml of 0.1 M HC1 and shaking for 2-3 hours at room temperature; and
12. Read the color in ELISA reader at 590 nm, the blanks are 0.1 M HCL; and the control plates are 100%.
The results of the above protocol done in duplicates are as follows:
1. SR18 inhibits growth of cancer HeLa cells by 30%-60% after 48 hours: * Growth inhibition by SR18 in saline: about 60%;
Growth inhibition by SR18 in silicone: about 30%.
2. SR18 inhibits growth of cancer H293 HEK cells by about 40%-60% after 24 hours:
Growth inhibition by SR18 in saline: about 60%;
Growth inhibition by SR18 in silicone: about 40%
3. SR18 inhibits growth of cancer H1299 cells by about 20% after 24 hours: Growth inhibition by SR18 in saline: about 20%;
Growth inhibition by SR18 in silicone: about 15%.
4. SR18 inhibits growth of cancer U20S cells by about 20% after 24 hours: Growth inhibition by SR18 in saline: about 20%;
Growth inhibition by SR18 in silicone: about 20%.
This experiment shows that the combinations of the invention, represented by SR18, surprisingly significantly inhibit growth of cancerous cells when present in the growth medium. Moreover, the combinations of the invention are able to inhibit growth of cancerous cells even without direct contact with the cells, i.e. when present in a silicon tubing placed around the plate.
Accordingly, the combinations of the invention are useful in inhibiting cancer growth.
Example 3
SR18 as a radiation protector
In order to demonstrate the protecting effect of the compositions of the invention on cells under stress, the expression of p53 in cells pretreated with SR18 and exposed to cellular irradiation was measured as an indication for cellular response to stress.
Cellular irradiation was performed according to Friedman et al., Biochem J., 405: 559-568, 2007, at a frequency of 875 MHz, at an intensity of 0.240 mW/cm2. Shortly, the method is as follows:
1. Grow Wi38, human lung diploid cell line (Wister Institute) in MEM (Minimal Eagle Medium) supplemented with 10% FCS, P/S, Glutamine and Pyruvate, in 6cm dishes;
2. Add SR18 30 μΐ to 6 cm dishes containing 2 ml medium or place a silicone tubing around the plates of the treated plates, and wait for 20 minutes;
3. Irradiate the cells for 1, 2, and 3 hours, at a frequency of 875 MHz, at an intensity of 0.240 mW/cm2;
4. Wash the cells twice with cold PBS;
5. Add 1 ml PBS and transfer the harvested cells to an Eppendorf tube;
6. Centrifuge the cells at cold, 4 minutes, 8000 rpm;
7. Re-suspend the cells pellet in Hunter buffer containing protease inhibitor, and incubate on ice for 30 minutes;
8. Freeze the samples in liquid nitrogen and thaw (37°C) three times;
9. Centrifuge the cells at cold, 5 minutes, 14000 rpm;
10. Perform a protein assay according to Bradford procedure to determine the protein concentration in the supernatant;
11. Add protein sample buffer, vortex for 30 seconds, and boil (98°C) for 4 minutes; and
12. Load equal amounts of protein onto a SDS/PAGE gel, and perform Western blotting using anti-p53 antibodies, and detect the proteins by ECL (enhanced chemical luminescence). In the treated plates, 20 minutes before irradiation began, SR18 was either added directly to the medium, or a silicon tubing containing SR18 was placed around the plate.
Results:
1. p53 expression was elevated after cellular irradiation for 1, 2 and 3 hours (Figure la).
2. p53 expression was markedly decreased when SR18 was present in the medium and even when present in silicon wrapped around the well (Figure lb).
3. p53 expression was not affected when cells were exposed to SR18 without irradiation.
These experiments show that the combinations of the invention, represented by SR18, surprisingly block the harmful effects of radiation on cells both when present in the growth medium, and even when present in a silicon tubing placed around the plate. Moreover, SR18 itself has no harmful effect on the cells as evident from the low expression of p53 in rested cells.
Accordingly, the combinations of the invention are useful as radiation protectors.
Example 4
SR18 as a radiation protector
In another attempt to demonstrate the protecting effect of the compositions of the invention on cells under stress, the phosphorylation of ERK in cells
pretreated with SR18 and exposed to cellular irradiation was measured as an indication for cellular response to stress.
Cellular irradiation was performed according to Friedman et al., Biochem J., 405: 559-568, 2007, at a frequency of 875 MHz, at an intensity of 0.240 mW/cm2. Shortly, the method is as follows:
1. Grow starved HeLa cells in Medium, in 6cm dishes;
2. Add SRI 8 to the medium or place a silicone tubing around the plates of the treated plates, and wait for 20 minutes;
3. Irradiate the cells for 5, 10, 15, 20, and 30 minutes, at a frequency of 875 MHz, at an intensity of 0.240 mW/cm2;
4. Wash the cells twice with cold PBS;
5. Harvest the cells essentially as described in Example 4 above (steps 4-11); and
6. Load equal amounts of protein onto a SDS/PAGE gel, and perform Western blotting using anti-phospho-ERK antibodies, and detect the proteins by ECL (enhanced chemical luminescence).
Results:
1. Cellular irradiation increases ERK phosphorylation and reached maximum level within 5 minutes (Figure 2a).
2. SR18 completely blocked ERK phosphorylation due to cellular irradiation.
Moreover, SR18 prevented even the basal ERK phosphorylation (Figures 2b and 2c).
These experiments show that SR18 surprisingly blocks the harmful effects of radiation on cells both when present in the growth medium, and even when present in a silicon tubing placed around the plate. Moreover, SR18 itself has no harmful effect on the cells as evident from the lack of phosphorylation of ERK.
Accordingly, SR18, as well as all the combinations of the invention are useful as radiation protectors. Example 5
SR18 does not effect normal metabolism
In order to demonstrate that the combinations of the invention do not interfere normal biological pathways, and even increases beneficial physiological responses, we analyzed ERK phosphorylation in cells exposed to epidermal growth factor (EGF) in HeLa cells.
Shortly, the method is as follows:
1. Grow starved HeLa cells in Medium, in 6cm dishes;
2. Add SR18 to the medium or place a silicone tubing around the plates of the treated plates, and wait for 20 minutes;
3. Add 50 ng/ml of EGF to the desired plates and wait 5, 10, 15, 20, and 30 minutes;
4. Wash the cells twice with cold PBS;
5. Harvest the cells essentially as described in Example 4 above (steps 4-11); and
6. Load equal amounts of protein onto a SDS/PAGE gel, and perform Western blotting using anti-phospho-ERK antibodies, and detect the proteins by ECL (enhanced chemical luminescence).
Results:
1. SR18 potentates only the ERK phosphorylation induced by EGF (Figures 3a and 3b).
This experiment shows that the combinations of the invention, represented by SR18, surprisingly increase the beneficial effect of useful pathways in cells when present in the growth medium, and even when present in a silicon tubing placed around the plate.
Accordingly, SR18, as well as all the combinations of the invention have a positive effect on cells and on the entire body.
While the present invention has been described above in connection with the certain illustrative embodiments, it is to be understood that other similar embodiments may be used or modifications and additions may be made to the described embodiments for performing the same function of the present invention without deviating therefrom. Furthermore, all embodiments disclosed are not necessarily in the alternative, as various embodiments of the invention may be combined to provide the desired characteristics. Variations can be made by one having ordinary skill in the art without departing from the spirit and scope of the invention. Therefore, the present invention should not be limited to any single illustrative embodiment, but rather construed in breadth and scope in accordance with the recitation of the attached claims.
Claims
1. A homeopathic combination, comprising the following homeopathic remedies:
- Formulation A;
- Formulation B
- Formulation C
- Formulation D
- Formulation E; and
- Formulation F.
2. The combination of claim 1, further comprising at least one of the following homeopathic remedies:
- Formulation G;
- Formulation H;
- Formulation I;
- Formulation J;
- Formulation K;
- Formulation L; and
- Formulation M.
3. A carrier substance, wherein said carrier is imprinted with the bioresonance of the combination of any one of claims 1 or 2.
4. The carrier of claim 3, which is a liquid.
5. The carrier of claim 3, which is a solid.
6. The carrier of claim 4, which is selected from the group consisting of: water, oil, salt solutions, glycerin, silicon, and alcohols.
7. The carrier of claim 3, wherein the imprinting is carried out separately for each Formulation.
8. The carrier of claim 3, wherein the various Formulations are first mixed into one solution and the combined bioresonances are imprinted onto the carrier in a single step.
9. The carrier of claim 3, wherein the various Formulations are first mixed into at least 2 solutions.
10. A wearable article of manufacture containing the carrier of claim 3 or the combination of any one of claims 1 or 2.
11. The article of manufacture of claim 10, which is an ornament such as a bracelet, a necklace, or a ring.
12. A wearable article of manufacture composed essentially of the carrier of claim 3.
13. The article of manufacture of any one of claims 10-12 which is suitable for therapy.
14. The article of manufacture of any one of claims 10-13 which is suitable for treating, preventing, and/or ameliorating at least one of the following diseases and conditions: cancer, infections (e.g. bacterial, viral, parasitical and fungal), metabolic disorders, neurodegenerative disorders, infertility, autoimmune diseases, immune deficiencies, heart diseases, and skin diseases.
15. The article of manufacture of any one of claims 10-13 which is suitable for treating, preventing, and/or ameliorating migraines, stress-related conditions, menstrual pains, and/or allergic reactions.
16. The article of manufacture of any one of claims 10-13 which is suitable for ameliorating side effects due to chemotherapy, radiotherapy and/or any other harmful or chronic therapy.
17. The article of manufacture of any one of claims 10-13 which is suitable for treating ADD and ADHD patients.
18. The article of manufacture of any one of claims 10-13 which is suitable for reducing the symptoms of the diseases and conditions outlined in any of claims claim 14-17.
19. The article of manufacture of any one of claims 10-12 which is suitable for protecting the wearer from radiation and/or for preventing radiation damages.
20. The article of manufacture of claim 19, wherein said radiation is ionizing radiation.
21. The article of manufacture of claim 19, wherein said radiation is nonionizing radiation and/or electromagnetic radiation.
22. A method for preparing the article of manufacture of any one of claims 10 or 11, which comprises:
- preparing the article of manufacture; and
- inserting therein the carrier of claim 3 or the combination of any one of claims 1 or 2.
23. A method for preparing the article of manufacture of claim 12, which comprises mixing the carrier with a stabilizing material, e.g. a plasticizer, and subsequently preparing the article of manufacture in any known method, e.g. press mold or cast mold.
24. A method of treating a patient, comprising providing said patient the article of manufacture of any one of claims 10-12 or the article of manufacture prepared by the method of any one of claims 22 or 23.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2011/000412 WO2012160549A2 (en) | 2011-05-26 | 2011-05-26 | Bioresonance therapy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IL2011/000412 WO2012160549A2 (en) | 2011-05-26 | 2011-05-26 | Bioresonance therapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2012160549A2 true WO2012160549A2 (en) | 2012-11-29 |
| WO2012160549A3 WO2012160549A3 (en) | 2016-05-19 |
Family
ID=47217828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IL2011/000412 WO2012160549A2 (en) | 2011-05-26 | 2011-05-26 | Bioresonance therapy |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2012160549A2 (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103416684A (en) * | 2013-08-05 | 2013-12-04 | 买世禄 | Production method of health-care food capable of improving hyperostosis and arthralgia by combining amino acid with multiple trace elements |
| WO2016044596A1 (en) * | 2014-09-18 | 2016-03-24 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| US10322063B2 (en) | 2013-03-19 | 2019-06-18 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| US10888707B2 (en) | 2013-03-19 | 2021-01-12 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| CN113349227A (en) * | 2021-05-12 | 2021-09-07 | 湖南省烟草公司株洲市公司 | Tobacco seed germination-promoting stress-resistant seedling-strengthening composition, preparation and use method |
| WO2024020704A1 (en) * | 2022-07-29 | 2024-02-01 | Wave Force Electronics Inc. | Wearable programmable bio-resonance device |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2486881A1 (en) * | 2002-05-20 | 2003-11-27 | Chemstop Pty Ltd | Process for the preparation and activation of substances and a means of producing same |
| US8999401B2 (en) * | 2007-05-09 | 2015-04-07 | Henry Steven Luria | Delivery system and method to deliver homeopathic complexes comprising homeopathic colored pigment products for cosmetic use |
| IE20080829A1 (en) * | 2007-10-10 | 2009-07-08 | Thomas Farrington | A homeopathic complex |
-
2011
- 2011-05-26 WO PCT/IL2011/000412 patent/WO2012160549A2/en active Application Filing
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10322063B2 (en) | 2013-03-19 | 2019-06-18 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| US10888707B2 (en) | 2013-03-19 | 2021-01-12 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| US11246799B2 (en) | 2013-03-19 | 2022-02-15 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| US11633618B2 (en) | 2013-03-19 | 2023-04-25 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| US11793716B2 (en) | 2013-03-19 | 2023-10-24 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| CN103416684A (en) * | 2013-08-05 | 2013-12-04 | 买世禄 | Production method of health-care food capable of improving hyperostosis and arthralgia by combining amino acid with multiple trace elements |
| WO2016044596A1 (en) * | 2014-09-18 | 2016-03-24 | Genovus Biotechnologies Inc. | Muscle optimization device and method |
| CN113349227A (en) * | 2021-05-12 | 2021-09-07 | 湖南省烟草公司株洲市公司 | Tobacco seed germination-promoting stress-resistant seedling-strengthening composition, preparation and use method |
| CN113349227B (en) * | 2021-05-12 | 2022-06-17 | 湖南省烟草公司株洲市公司 | Tobacco seed germination-promoting stress-resistant seedling-strengthening composition, preparation and use method |
| WO2024020704A1 (en) * | 2022-07-29 | 2024-02-01 | Wave Force Electronics Inc. | Wearable programmable bio-resonance device |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012160549A3 (en) | 2016-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mortezaee et al. | Metformin as a radiation modifier; implications to normal tissue protection and tumor sensitization | |
| Zhang et al. | Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability | |
| WO2012160549A2 (en) | Bioresonance therapy | |
| Mohammadi et al. | Urtica dioica extract inhibits proliferation and induces apoptosis and related gene expression of breast cancer cells in vitro and in vivo | |
| EP2595655A2 (en) | Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition | |
| CN105943558A (en) | Application of periplaneta americana in preparation of drug for preventing and treating radiation-induced damage | |
| Jiang et al. | Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts | |
| CN102861193B (en) | Traditional Chinese medicine composition for treating gastric cancer | |
| Kim et al. | The fruit hull of Gleditsia sinensis enhances the anti-tumor effect of cis-diammine dichloridoplatinum II (Cisplatin) | |
| CN111658756A (en) | Plaster for treating complications caused by malignant tumor and preparation method thereof | |
| CN102670977B (en) | Chinese medicinal composition for treating arthralgia, preparation method and applications of Chinese medicinal composition | |
| CN102579709A (en) | Scar preventing and removing burn oil and preparation method thereof | |
| CN103405653B (en) | External preparation for treating gouty arthritis | |
| CN101904932B (en) | External application Chinese ointment for preventing and curing skin injury caused by ionizing radiation | |
| CN102274317A (en) | Chinese medicinal composition for treating cancers and preparation method thereof | |
| Xue et al. | Mitigation of chronic unpredictable stress–induced cognitive deficits in mice by Lycium barbarum L (Solanaceae) polysaccharides | |
| CN102302559B (en) | Medicament for treating respiratory system diseases and application thereof | |
| Pal | A review on an Ayurvedic approach for cancer treatment developed by Vaidya Balendu Prakash | |
| RU2346696C2 (en) | Method of human immune system stimulation using activated platinoids-containing mineral, method of mineral activation and composition with immune system stimulation properties | |
| CN113230316A (en) | Application of peony and licorice decoction preparation in preventing and treating tumor diseases | |
| CN106309758A (en) | Pharmaceutical composition with efficacy of resisting gastrointestinal cancer | |
| CN106890189A (en) | Application of the chonglou saponin in antineoplastic sensitizer is prepared | |
| Wang et al. | The effect of acupuncture and selection of acupoints on myelosuppression after chemotherapy | |
| CN104547150A (en) | Application of inflammation-diminishing and pain-relieving external medicine as oral agent for treating tumors and ulcerative carbuncles | |
| CN109985120A (en) | A kind of Chinese medicine composition that treating eczema and its application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11866342 Country of ref document: EP Kind code of ref document: A2 |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 11866342 Country of ref document: EP Kind code of ref document: A2 |